Continuing the spate of stunning news about COVID-19 vaccines, the biotech company Moderna announced the final results of the 30,000-person efficacy trial for its candidate in a press release today: Only 11 people who received two doses of the vaccine … Continue reading (Science Magazine) ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19